logo-loader
RNS
Accrol Group Holdings PLC

Accrol Group Hldgs - Result of General Meeting

RNS Number : 0415G
Accrol Group Holdings PLC
20 November 2020
 

20 November 2020

 

Accrol Group Holdings plc

(the "Company")

AIM: ACRL

 

Result of General Meeting

 

Accrol Group Holdings plc, a leading independent tissue converter in the UK, announces that, at its general meeting held earlier today (the "General Meeting"), all resolutions proposed at the General Meeting (the "Resolutions") were duly passed.

 

Following the approval of the Resolutions, the placing to raise £38.5 million (before expenses) (the "Placing") and the open offer to raise c.£4.1 million (before expenses) (the "Open Offer"), each as described in more detail in the announcement made by the Company on 3 November 2020, remain conditional on admission of the new ordinary shares being issued pursuant to the Placing to trading on AIM becoming effective, which is expected to occur at 8am on Monday, 23 November 2020.

 

 

For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000



Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas




Deloitte LLP (Financial Adviser)

Tel: +44 (0) 20 7936 3000

Andrew Westbrook / Chris Nicholls




Belvedere Communications Limited


Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

Llew Angus

Tel:  +44 (0) 7407 023 147


accrolpr@belvederepr.com

 

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:

 

·

A manufacturing, storage, and distribution facility in Blackburn;

·

A storage and administrative centre in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage, and distribution facility in Leyland.

 

For more information, please visit www.accrol.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFEFFFSESSEDF
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read